MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
20.08
+0.58 (2.97%)
Feb 5, 2025, 11:54 AM EST - Market open
MediWound Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MediWound stock has a target of 25, which predicts an increase of 24.50% from the current stock price of 20.08.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for MediWound is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +24.50% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $25 | Strong Buy | Maintains | $28 → $25 | +24.50% | Nov 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +39.44% | Oct 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +39.44% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +39.44% | Jul 16, 2024 |
Financial Forecast
Revenue This Year
20.58M
from 18.69M
Increased by 10.15%
Revenue Next Year
25.86M
from 20.58M
Increased by 25.62%
EPS This Year
-3.42
from -0.75
EPS Next Year
-2.36
from -3.42
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 21.9M | 28.6M | 35.1M | |||
| Avg | 20.6M | 25.9M | 32.2M | |||
| Low | 19.4M | 23.5M | 29.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 17.3% | 38.8% | 35.8% | |||
| Avg | 10.1% | 25.6% | 24.6% | |||
| Low | 4.0% | 14.3% | 13.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -3.43 | -1.92 | -1.41 | |||
| Avg | -3.42 | -2.36 | -1.64 | |||
| Low | -3.38 | -2.64 | -1.83 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.